| Financial Year |
March 31 2023 |
| Monetary Funds |
34,276,995.46 |
| Held-for-trading Financial Assets |
109,510,863.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
753,487,724.67 |
| Advances to Suppliers |
38,601,709.59 |
| Other Receivables |
31,688,635.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,378,145.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
769,802.68 |
| Total Current Assets |
970,713,876.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,272.25 |
| Investment Properties |
-- |
| Fixed Assetes |
119,556,400.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,017,726.31 |
| R&D expenses |
-- |
| Goodwill |
9,948,834.61 |
| Long-Term Deferred and Prepaid Expenses |
44,734.32 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
200,000.00 |
| Sub-Total of Non-Current Assets |
723,662,498.56 |
| Total Assets |
1,694,376,375.44 |
| Short-Term Loans |
104,137,988.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
162,232,399.76 |
| Accounts Received In Advance |
3,611,434.27 |
| Employee Compensation Payable |
13,454,083.41 |
| Taxes Payable |
114,708,606.83 |
| Interest Payable |
-- |
| Dividend Payable |
749,072.68 |
| Other payables |
58,006,386.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,638,393.03 |
| Other Current Liabilities |
68,996.53 |
| Sub-Total of Current Liabilities |
462,782,042.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,631,572.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
56,690,897.46 |
| Total Liabilities |
519,472,940.10 |
| Paid-In Capital(Or Share Stock) |
507,420,732.00 |
| Capital Surplus |
1,028,387,262.12 |
| Surplus Reserve |
162,241,200.56 |
| LESS:Treasury Stock |
2,268,699.94 |
| Undistributed Profits |
-513,192,563.02 |
| Minority Stockholder's Interest |
-7,684,496.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,182,587,931.72 |
| Owner's Equity（Stockholder's Equity） |
1,174,903,435.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,694,376,375.44 |
